Literature DB >> 7634867

Clinical significance of fibrillatory wave amplitude. A clue to left atrial appendage function in nonrheumatic atrial fibrillation.

Y H Li1, J J Hwang, Y Z Tseng, P Kuan, W P Lien.   

Abstract

Seventy-eight patients with chronic nonrheumatic atrial fibrillation were studied by transesophageal echocardiography with regard to the left atrial appendage function and its relation to the coarseness of atrial fibrillation on electrocardiogram. These 78 patients (52 men and 26 women; mean age, 66 +/- 10 years; range, 40 to 94 years) were classified into two groups according to the presence of coarse (group 1, n = 46; those with the greatest amplitude of fibrillatory wave in lead V1 > or = 1 mm) or fine (group 2, n = 32; those without the coarse fibrillatory wave in lead V1) atrial fibrillation on a standard 12-lead electrocardiogram within 1 month of echocardiographic studies. There were no significant differences in age, sex, mean duration of atrial fibrillation, left ventricular end-diastolic dimension, left ventricular end-systolic dimension, left ventricular ejection fraction, and left atrial dimension between the two groups. In group 1, however, the left atrial appendage ejection fraction (24.4 +/- 14.2% vs 32.6 +/- 14.8%; p < 0.05) and the peak emptying velocity (21.7 +/- 12.6 cm/s vs 30.4 +/- 14.3 cm/s; p < 0.01) were lower than those in group 2. There were higher incidences of left atrial appendage spontaneous echo contrast (26/46 vs 7/32; p < 0.005) and thrombus (8/46 vs 0/32; p < 0.05) in group 1 patients. The coarse atrial fibrillation revealed a sensitivity of 80.0%, a specificity of 58.1%, a positive predictive value of 60.9%, and a negative predictive value of 78.1% for the presence of left atrial appendage spontaneous echo contrast and/or thrombus formation. In conclusion, in patients with coarse nonrheumatic atrial fibrillation, the left atrial appendage function is usually poor and the incidence of spontaneous echo contrast and thrombus formation appears to be higher in these patients.

Entities:  

Mesh:

Year:  1995        PMID: 7634867     DOI: 10.1378/chest.108.2.359

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Identification of transmural necrosis along a linear catheter ablation lesion during atrial fibrillation and sinus rhythm.

Authors:  Javier E Sanchez; G Neal Kay; Michael E Benser; Jeffrey A Hall; Gregory P Walcott; William M Smith; Raymond E Ideker
Journal:  J Interv Card Electrophysiol       Date:  2003-02       Impact factor: 1.900

2.  Fine versus coarse atrial fibrillation in rheumatic mitral stenosis: The impact of aging and the clinical significance.

Authors:  Leili Pourafkari; Aidin Baghbani-Oskouei; Naser Aslanabadi; Arezou Tajlil; Samad Ghaffari; Ali Mosavi Sadigh; Safa Savadi-Oskouei; Elgar Enamzadeh; Raziyeh Parizad; Nader D Nader
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-03-05       Impact factor: 1.468

Review 3.  Left atrial appendage: structure, function, and role in thromboembolism.

Authors:  N M Al-Saady; O A Obel; A J Camm
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 4.  Left Atrial Cardiomyopathy - A Challenging Diagnosis.

Authors:  Fabienne Kreimer; Michael Gotzmann
Journal:  Front Cardiovasc Med       Date:  2022-06-30

5.  Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation.

Authors:  Isabelle Nault; Nicolas Lellouche; Seiichiro Matsuo; Sébastien Knecht; Matthew Wright; Kang-Teng Lim; Frederic Sacher; Pyotr Platonov; Antoine Deplagne; Pierre Bordachar; Nicolas Derval; Mark D O'Neill; George J Klein; Mélèze Hocini; Pierre Jaïs; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Interv Card Electrophysiol       Date:  2009-04-30       Impact factor: 1.900

6.  Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry.

Authors:  Tetsuma Kawaji; Hisashi Ogawa; Yasuhiro Hamatani; Masashi Kato; Takafumi Yokomatsu; Shinji Miki; Mitsuru Abe; Masaharu Akao
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.